🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the producers of acetaminophen, claiming the corporations hid safety concerns that the medication presented to children's brain development.

This legal action comes thirty days after Donald Trump promoted an unsubstantiated connection between taking Tylenol - alternatively called acetaminophen - throughout gestation and autism in children.

Paxton is taking legal action against J&J, which previously sold the drug, the sole analgesic suggested for pregnant women, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "misled consumers by gaining financially from discomfort and pushing pills without regard for the potential hazards."

The manufacturer states there is lacking scientific proof connecting Tylenol to autism.

"These corporations lied for decades, intentionally threatening numerous people to line their pockets," the attorney general, a Republican, declared.

Kenvue stated officially that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the potential impact that could have on the well-being of American women and children."

On its official site, the company also mentioned it had "consistently assessed the applicable studies and there is no credible data that shows a established connection between consuming paracetamol and autism."

Groups representing doctors and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has said acetaminophen - the primary component in acetaminophen - is a restricted selection for expectant mothers to address pain and fever, which can present serious health risks if ignored.

"In more than two decades of research on the utilization of acetaminophen in gestation, not a single reputable study has definitively established that the use of acetaminophen in any trimester of gestation results in brain development issues in offspring," the association stated.

This legal action references latest statements from the former administration in claiming the medication is reportedly hazardous.

Recently, Trump raised alarms from medical authorities when he instructed expectant mothers to "struggle intensely" not to use Tylenol when sick.

Federal regulators then released a statement that physicians should consider limiting the consumption of Tylenol, while also declaring that "a direct connection" between the medication and autism spectrum disorder in young ones has remains unverified.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had pledged in April to initiate "extensive scientific investigation" that would identify the cause of autism in a short period.

But authorities advised that finding a sole reason of autism spectrum disorder - considered by experts to be the consequence of a intricate combination of genetic and environmental factors - would be difficult.

Autism is a type of lifelong neurodivergence and disability that influences how persons experience and interact with the world, and is identified using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is seeking the Senate - claims Kenvue and Johnson & Johnson "willfully ignored and tried to quiet the research" around paracetamol and autism spectrum disorder.

The lawsuit seeks to make the corporations "eliminate any commercial messaging" that states Tylenol is reliable for women during pregnancy.

The court case echoes the grievances of a group of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in 2022.

Judicial authorities dismissed the legal action, saying investigations from the parents' expert witnesses was lacking definitive proof.